ESC 365 - Antihypertensive treatment during pregnancy and maternal and fetal outcomes

ESC Professional Premium Access

Antihypertensive treatment during pregnancy and maternal and fetal outcomes

Session: Pharmacological management of hypertension

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor J. Vaclavik (Ostrava, CZ)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Jan Vaclavik

University Hospital Ostrava, Ostrava (Czechia)

2 followers

5 more presentations in this session

Subgroup results from KARDIA-2: impact of demographic and baseline disease characteristics on zilebesiran response in patients with hypertension uncontrolled by a standard oral antihypertensive

Speaker: Doctor M. Saxena (London, GB)

Safety, tolerability and blood pressure lowering of the innovative guanylyl cyclase a-receptor activator MANP in an ethnically diverse resistant hypertension population: a phase 1B clinical trial

Speaker: Professor H. Chen (Rochester, US)

Antihypertensive treatment of masked hypertension guided by ambulatory blood pressure monitoring: a double-blind, placebo-controlled trial

Speaker: Doctor D. Zhang (Shanghai, CN)

Angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers vs. calcium channel blockers for 12,478 young hypertensive patients under 40 in 10-year follow-up

Speaker: Doctor S. Jo (Anyang-Si- Gyeonggi-Do, KR)

Blood pressure lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of 500 randomised, double-blind placebo-controlled trials

Speaker: Doctor N. Wang (Sydney, AU)

Access the full session

Pharmacological management of hypertension

Speakers: Professor J. Vaclavik, Doctor M. Saxena, Professor H. Chen, Doctor D. Zhang, Doctor S. Jo...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources